EFLUELDA
INJ SUS ISP 5X0,7ML
| SÚKL code | 0239063 |
|---|---|
| Name of the product | EFLUELDA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | EFLUELDA |
| Supplement | INJ SUS ISP 5X0,7ML |
| Strenght | |
| Pharmaceutical form | Suspension for injection in pre-filled syringe |
| Package | 5X0,7ML |
| Route | Subcutaneous/intramucsular use |
| Language of the pack | Czech |
| Wrap type | Pre-filled syringe |
| Legal status | na lékařský předpis |
| Active substance |
INFLUENZA VIRUS B/PHUKET (INFLUENZAE VIRUS B/PHUKET) INFLUENZA VIRUS A/VICTORIA (H1N1) (INFLUENZAE VIRUS A/VICTORIA (H1N1)) INFLUENZA VIRUS A/CAMBODIA (H3N2) (INFLUENZAE VIRUS A/CAMBODIA (H3N2)) INFLUENZA VIRUS B/WASHINGTON (INFLUENZAE VIRUS B/WASHINGTON) |
| ATC group | J07BB02 |
| ATC group name | CHŘIPKA, INAKTIVOVANÁ VAKCÍNA, ŠTĚPENÝ VIRUS NEBO POVRCHOVÝ ANTIGEN |
Marketing authorisation information
| Registration Number | 59/ 173/19-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Sanofi Pasteur, Lyon |
| MA Holder country | FRANCIE |
cz